|
MY164523A
(en)
|
2000-05-23 |
2017-12-29 |
Univ Degli Studi Cagliari |
Methods and compositions for treating hepatitis c virus
|
|
AU2003298658A1
(en)
|
2002-11-15 |
2004-06-15 |
Idenix (Cayman) Limited |
2'-branched nucleosides and flaviviridae mutation
|
|
RU2358979C2
(ru)
|
2003-05-30 |
2009-06-20 |
Фармассет, Инк. |
Модифицированные фторированные аналоги нуклеозида
|
|
ES2725457T3
(es)
*
|
2004-09-14 |
2019-09-24 |
Gilead Pharmasset Llc |
Preparación de ribofuranosil pirimidinas y purinas 2'fluoro-2'-alquil-sustituidas u otras opcionalmente sustituidas y sus derivados
|
|
US9117261B2
(en)
|
2004-11-16 |
2015-08-25 |
Thomson Licensing |
Film grain SEI message insertion for bit-accurate simulation in a video system
|
|
ES2381982T3
(es)
|
2004-11-16 |
2012-06-04 |
Thomson Licensing |
Método de simulación del grano de película basado en coeficientes de transformación previamente generados por ordenador
|
|
CA2587117C
(en)
|
2004-11-17 |
2014-02-11 |
Thomson Licensing |
Bit-accurate film grain simulation method based on pre-computed transformed coefficients
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
US10715834B2
(en)
|
2007-05-10 |
2020-07-14 |
Interdigital Vc Holdings, Inc. |
Film grain simulation based on pre-computed transform coefficients
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
AR074897A1
(es)
|
2008-12-23 |
2011-02-23 |
Pharmasset Inc |
Fosforamidatos de nucleosidos
|
|
CL2009002206A1
(es)
|
2008-12-23 |
2011-08-26 |
Gilead Pharmasset Llc |
Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
|
|
MX2011006890A
(es)
|
2008-12-23 |
2011-07-20 |
Pharmasset Inc |
Analogos de nucleosidos.
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
TWI576352B
(zh)
|
2009-05-20 |
2017-04-01 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
TW201136945A
(en)
|
2010-03-31 |
2011-11-01 |
Pharmasset Inc |
Purine nucleoside phosphoramidate
|
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
|
AP2012006535A0
(en)
|
2010-03-31 |
2012-10-31 |
Gilead Pharmasset Llc |
Stereoselective synthesis of phosphorous containing actives
|
|
JP5716500B2
(ja)
*
|
2010-06-03 |
2015-05-13 |
セントラル硝子株式会社 |
（２Ｒ）−２−フルオロ−２−Ｃ−メチル−Ｄ−リボノ−γ−ラクトン類前駆体の製造方法
|
|
ES2716158T3
(es)
|
2010-11-30 |
2019-06-10 |
Gilead Pharmasset Llc |
2'-spiro-nucleótidos para el tratamiento de hepatitis C
|
|
US9243025B2
(en)
|
2011-03-31 |
2016-01-26 |
Idenix Pharmaceuticals, Llc |
Compounds and pharmaceutical compositions for the treatment of viral infections
|
|
US9403863B2
(en)
|
2011-09-12 |
2016-08-02 |
Idenix Pharmaceuticals Llc |
Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
|
|
HRP20180237T4
(hr)
|
2011-09-16 |
2020-12-11 |
Gilead Pharmasset Llc |
Metode za liječenje hcv-a
|
|
AR089650A1
(es)
|
2011-10-14 |
2014-09-10 |
Idenix Pharmaceuticals Inc |
Fosfatos 3,5-ciclicos sustituidos de compuestos de nucleotido de purina y composiciones farmaceuticas para el tratamiento de infecciones virales
|
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
|
DE112012003510T5
(de)
|
2011-10-21 |
2015-03-19 |
Abbvie Inc. |
Verfahren zur Behandlung von HCV umfassend mindestens zwei direkt wirkende antivirale Wirkstoffe, Ribavirin aber nicht Interferon
|
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
|
CN104023726A
(zh)
|
2011-10-21 |
2014-09-03 |
艾伯维公司 |
用于治疗hcv的一种或多种daa的联合治疗(例如，与abt-072或abt-333)
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
EP2852604B1
(en)
|
2012-05-22 |
2017-04-12 |
Idenix Pharmaceuticals LLC |
3',5'-cyclic phosphoramidate prodrugs for hcv infection
|
|
MD20140134A2
(ro)
|
2012-05-22 |
2015-04-30 |
Idenix Pharmaceuticals, Inc. |
Compuşi ai D-aminoacizilor pentru tratamentul bolilor hepatice
|
|
WO2013177195A1
(en)
|
2012-05-22 |
2013-11-28 |
Idenix Pharmaceuticals, Inc. |
3',5'-cyclic phosphate prodrugs for hcv infection
|
|
PT2861611T
(pt)
|
2012-05-25 |
2016-10-11 |
Janssen Sciences Ireland Uc |
Nucleósidos de espirooxetano de uracilo
|
|
RU2014149148A
(ru)
*
|
2012-05-29 |
2016-07-20 |
Ф. Хоффманн-Ля Рош Аг |
Способ получения соединений 2-дезокси-2-фтор-2-метил-d-рибофуранозил нуклеозида
|
|
CN103450148B
(zh)
*
|
2012-06-04 |
2018-06-12 |
浙江九洲药业股份有限公司 |
一种五元环硫酸酯化合物的合成方法
|
|
WO2014052638A1
(en)
|
2012-09-27 |
2014-04-03 |
Idenix Pharmaceuticals, Inc. |
Esters and malonates of sate prodrugs
|
|
ES2674980T3
(es)
|
2012-10-08 |
2018-07-05 |
Idenix Pharmaceuticals Llc |
Análogos de 2'-cloro nucleósidos para infección por VHC
|
|
CN103724301A
(zh)
|
2012-10-10 |
2014-04-16 |
上海特化医药科技有限公司 |
(2r)-2-脱氧-2,2-二取代-1,4-核糖内酯及其制备方法和用途
|
|
WO2014066239A1
(en)
|
2012-10-22 |
2014-05-01 |
Idenix Pharmaceuticals, Inc. |
2',4'-bridged nucleosides for hcv infection
|
|
US9211300B2
(en)
|
2012-12-19 |
2015-12-15 |
Idenix Pharmaceuticals Llc |
4′-fluoro nucleosides for the treatment of HCV
|
|
CN103012386B
(zh)
*
|
2012-12-26 |
2015-04-01 |
浙江普洛得邦制药有限公司 |
一种五元环状硫酸酯的制备方法
|
|
EP2950786B1
(en)
|
2013-01-31 |
2019-11-27 |
Gilead Pharmasset LLC |
Combination formulation of two antiviral compounds
|
|
US10034893B2
(en)
|
2013-02-01 |
2018-07-31 |
Enanta Pharmaceuticals, Inc. |
5, 6-D2 uridine nucleoside/tide derivatives
|
|
WO2014137930A1
(en)
|
2013-03-04 |
2014-09-12 |
Idenix Pharmaceuticals, Inc. |
Thiophosphate nucleosides for the treatment of hcv
|
|
WO2014137926A1
(en)
|
2013-03-04 |
2014-09-12 |
Idenix Pharmaceuticals, Inc. |
3'-deoxy nucleosides for the treatment of hcv
|
|
EP2970357B1
(en)
|
2013-03-13 |
2025-01-01 |
Idenix Pharmaceuticals LLC |
Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
|
|
EP2981542B1
(en)
|
2013-04-01 |
2021-09-15 |
Idenix Pharmaceuticals LLC |
2',4'-fluoro nucleosides for the treatment of hcv
|
|
EP3004130B1
(en)
|
2013-06-05 |
2019-08-07 |
Idenix Pharmaceuticals LLC. |
1',4'-thio nucleosides for the treatment of hcv
|
|
US20150037282A1
(en)
|
2013-08-01 |
2015-02-05 |
Idenix Pharmaceuticals, Inc. |
D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
|
|
EA201690473A1
(ru)
|
2013-08-27 |
2017-03-31 |
ГАЙЛИД ФАРМАССЕТ ЭлЭлСи |
Комбинированный состав двух противовирусных соединений
|
|
CN104447923B
(zh)
*
|
2013-09-23 |
2018-03-30 |
中国药科大学 |
2’‑脱氧‑2’‑氟‑2’‑甲基核苷衍生物及其制备方法与在制药中的用途
|
|
EP3131914B1
(en)
|
2014-04-16 |
2023-05-10 |
Idenix Pharmaceuticals LLC |
3'-substituted methyl or alkynyl nucleosides for the treatment of hcv
|
|
US9675632B2
(en)
|
2014-08-26 |
2017-06-13 |
Enanta Pharmaceuticals, Inc. |
Nucleoside and nucleotide derivatives
|
|
WO2016042576A1
(en)
|
2014-09-16 |
2016-03-24 |
Cadila Healthcare Limited |
Co-crystal of sofosbuvir and amino acid and process for preparation thereof
|
|
CN104744539A
(zh)
*
|
2014-09-19 |
2015-07-01 |
上海皓元生物医药科技有限公司 |
一种(2’r)-2’-脱氧-2’-氟-2’-甲基脲苷的合成方法
|
|
CN104327138B
(zh)
*
|
2014-10-21 |
2017-05-10 |
齐鲁制药有限公司 |
Psi‑7977中间体化合物的制备方法
|
|
WO2016073756A1
(en)
|
2014-11-06 |
2016-05-12 |
Enanta Pharmaceuticals, Inc. |
Deuterated nucleoside/tide derivatives
|
|
US9732110B2
(en)
|
2014-12-05 |
2017-08-15 |
Enanta Pharmaceuticals, Inc. |
Nucleoside and nucleotide derivatives
|
|
CN104610404B
(zh)
*
|
2015-01-16 |
2016-04-06 |
南通常佑药业科技有限公司 |
一种呋喃核糖磷酸酯衍生物的制备方法
|
|
FI3265102T3
(fi)
|
2015-03-06 |
2025-10-31 |
Atea Pharmaceuticals Inc |
Beta-d-2'-deoksi-2'-alfa-fluori-2'-beta-c-substituoituja-2-modifioituja-n6-substituoituja puriininukleotideja hcv-hoitoa varten
|
|
CN104829672B
(zh)
*
|
2015-05-19 |
2018-03-13 |
江苏福瑞生物医药有限公司 |
一种药物中间体的合成方法
|
|
CN105061535A
(zh)
*
|
2015-09-02 |
2015-11-18 |
江苏科本医药化学有限公司 |
一种索非布韦中间体的合成方法
|
|
CN106554333B
(zh)
*
|
2015-09-29 |
2018-11-30 |
江苏福瑞生物医药有限公司 |
一种药物中间体的合成方法
|
|
CN106608896B
(zh)
*
|
2015-10-26 |
2019-08-27 |
江苏福瑞康泰药业有限公司 |
一种药物中间体的合成方法
|
|
CN105418547A
(zh)
*
|
2015-11-17 |
2016-03-23 |
海门慧聚药业有限公司 |
索非布韦关键中间体的制备
|
|
CN105503983B
(zh)
*
|
2015-12-17 |
2019-06-28 |
江苏阿尔法药业有限公司 |
索菲布韦中间体及其衍生物的制备方法
|
|
CN105566422B
(zh)
*
|
2015-12-29 |
2019-06-25 |
江苏阿尔法药业有限公司 |
索菲布韦中间体或其衍生物的制备方法
|
|
JP7129703B2
(ja)
|
2016-04-28 |
2022-09-02 |
エモリー ユニバーシティー |
アルキン含有ヌクレオチド及びヌクレオシド治療組成物並びにそれらに関連した使用
|
|
WO2018013937A1
(en)
|
2016-07-14 |
2018-01-18 |
Atea Pharmaceuticals, Inc. |
Beta-d-2'-deoxy-2'-alpha-fluoro-2'-beta-c-substituted-4'-fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection
|
|
US10239910B2
(en)
|
2016-07-20 |
2019-03-26 |
Optimus Drugs (P) Limited |
Process for the preparation of sofosbuvir
|
|
PT3512863T
(pt)
|
2016-09-07 |
2022-03-09 |
Atea Pharmaceuticals Inc |
Nucleótidos de purina 2'-substituídos-n6-substituídos para tratamento de vírus de rna
|
|
CN115477679A
(zh)
|
2017-02-01 |
2022-12-16 |
阿堤亚制药公司 |
用于治疗丙型肝炎病毒的核苷酸半硫酸盐
|
|
CN106810515A
(zh)
*
|
2017-02-06 |
2017-06-09 |
抚州市星辰药业有限公司 |
一种合成索非布韦的中间体化合物及其合成方法
|
|
CN109422789A
(zh)
*
|
2017-08-28 |
2019-03-05 |
常州制药厂有限公司 |
一种索非布韦的制备工艺改进方法
|
|
CN112351799A
(zh)
|
2018-04-10 |
2021-02-09 |
阿堤亚制药公司 |
具有硬化的hcv感染患者的治疗
|
|
CN108675984A
(zh)
*
|
2018-06-22 |
2018-10-19 |
江苏阿尔法药业有限公司 |
索非布韦中间体的制备方法
|
|
CN111606961A
(zh)
*
|
2019-02-26 |
2020-09-01 |
顾世海 |
一种(2’r)-2’-脱氧-2’-氟-2’-甲基脲苷的工艺生产方法
|
|
CN111040010A
(zh)
*
|
2019-12-23 |
2020-04-21 |
上海红蓝医药科技有限公司 |
一种索非布韦中间体的合成方法
|
|
US10874687B1
(en)
|
2020-02-27 |
2020-12-29 |
Atea Pharmaceuticals, Inc. |
Highly active compounds against COVID-19
|
|
WO2022164941A1
(en)
|
2021-01-26 |
2022-08-04 |
Atea Pharmaceuticals, Inc. |
Advantageous morphic form of at-527 hemi-sulfate salt
|
|
AU2022291927A1
(en)
|
2021-06-17 |
2024-01-04 |
Atea Pharmaceuticals, Inc. |
Advantageous anti-hcv combination therapy
|